^
Association details:
| Biomarker: | FGFR2 M540_I541insMM |
|---|---|
| Cancer: | Cholangiocarcinoma |
| Drug: | Pemazyre (pemigatinib) (FGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma
Published date:
09/02/2022
Excerpt:
In addition, one patient treated with pemigatinib developed FGFR2 M540_I541insMM alteration at time of resistance…
DOI:
10.1007/s11523-022-00914-w
